Chindex International Inc., a United States company that provides healthcare services in China through the United Family Healthcare network, said it has received a better buyout offer than the one it got from a consortium led by private equity firm TPG Inc., the Wall Street Journal reported Monday.
The new offer from an undisclosed buyer is US$23 a share and the company’s transaction committee of independent directors has determined it to be a superior proposal.
In February, Chindex agreed to an offer worth US$19.50 a share, or US$369 million from the TPG consortium which includes Shanghai Fosun Pharmaceutical Group Co. and Chindex chief executive Roberta Lipson, the report said.
The transaction committee has not changed its recommendation that Chindex shareholders vote to approve the pending merger, the company was quoted as saying.
– Contact HKEJ at [email protected]